Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/10380| Title: | COVID-19: Vaccines, myths, and misconceptions in Africa Experts share their insights |
| Authors: | Malande, Oliver Ombeva Musyoki, Andrew Munyalo Adamu, Victor Eneojo Mun- ube, Deogratias Hokororo, Adolfine Sabahelzain, Majdi Nzoka, Mutunga Afaayo, Rachel Nakatugga Chege, Christine Karanja Omayo, Leonidah Nyamusi Nkwinika, Var- setile Varster |
| Keywords: | Vaccines Myths Misconceptions COVID-19 |
| Issue Date: | Oct-2021 |
| Publisher: | Africa health |
| Abstract: | Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. At the start of the pandemic, scientists and pharmaceutical companies frantically searched for an effective vaccine. 1-4 Various platforms have employed traditional vaccine develop- ment approaches like live attenuated virus, inactivated virus, recombinant-protein based, viral-like particles and explored newer platforms like non-replicating viral vector, replicating viral vector, peptide-based, DNA and RNA based vaccines.1-8 There are currently over 300 COVID-19 candidate vaccines at different levels of development but about ten are currently being used. |
| URI: | file:///home/systems/Downloads/COVID-19Vaccinesmythsandmisconception.pdf http://ir.mu.ac.ke:8080/jspui/handle/123456789/10380 |
| Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.